PharmStockPharmacy Stock

Prandin
Prandin

1.67
A generic medicine indicated for diabetes. Stimulates pancreatic insulin release to lower blood glucose levels after carbohydrate intake.
Ingredient
Repaglinide
Category
Diabetes Management
Availability
In Stock
Delivery Time
Airmail (14-21 days) | Trackable (5-9 days)
Shipped in a discreet, unmarked envelope with all required documents enclosed.

Product Sheet

Active Ingredient(s)
Repaglinide
Reference Brand
Repaglinide
Product Origin
Generic Alternative
Reference Manufacturer
Novo Nordisk
Product Form
Tablet
Regulatory Classification
Prescription Only Medicine
Primary Category
Antidiabetics
Product Category
Meglitinide
Pharmacological Class
Antidiabetic
Clinical Indications
Type 2 diabetes mellitus
Manufacturer Description
Indicated to address postprandial glycemic elevations to manage type 2 diabetes and support mealtime insulin release.
Mechanism of Action
Stimulates rapid insulin release from pancreatic beta cells by closing ATP-sensitive potassium channels.
Route of Administration
Oral
Onset Time
30 minutes
Duration
3–4 hours
Contraindications
Diabetic ketoacidosis, Type 1 diabetes, Concurrent gemfibrozil use, Severe liver disease
Severe Adverse Events
Severe hypoglycemia — requires immediate medical attention
Common Side Effects
Nausea, Headache, Indigestion
Uncommon Side Effects
Hypoglycemia, Weight gain, Diarrhea
Drug Interactions
Gemfibrozil, Ketoconazole, Rifampin
Pregnancy Safety Warnings
TGA Category C: Use if clearly indicated. Insulin preferred in pregnancy. Breastfeeding: Not recommended.
Age Restrictions
Approved for adults.
Storage Guidelines
Store below 25°C.
Related Products
Starlix
Information related to Prandin is compiled and periodically reviewed with reference to established medical sources and prescribing guidance. Content is provided for general reference and should be confirmed with a registered healthcare professional before use.
Categories
where to buy Asthma Inhalers PBS - Symbicort Turbuhaler Australia